GLP-1 Cost Without Insurance

Paying cash for a GLP-1 medicine means facing the list price, and for the branded pens that runs from about $1,000 to about $1,350 a month. This hub page sets out the four branded list prices, explains why the quote you are given can differ from all of them, and covers the legitimate routes that bring the real price down.

Person reviewing medicine costs with a notebook and calculator at home

The four branded list prices

These are the approximate US list prices used across this site. A list price is the manufacturer's reference price before insurance, discounts or pharmacy pricing, so it is the right starting point for comparison and rarely the exact number anyone pays.

MedicineIngredient and approved useApproximate US list price per month
OzempicSemaglutide, type 2 diabetesAbout $1,000
WegovySemaglutide, weight managementAbout $1,350
MounjaroTirzepatide, type 2 diabetesAbout $1,080
ZepboundTirzepatide, weight managementAbout $1,060

The Ozempic price guide and the Zepbound cost without insurance guide break two of these down in full. The cheapest GLP-1 without insurance guide ranks every option, branded and compounded, in one table.

Why the quote you receive varies

Pharmacies set their own cash prices

The list price is a reference, not a register price. Pharmacies apply their own pricing and contracts, so the same pen at the same dose can be quoted at noticeably different cash prices by different pharmacies. Getting two or three cash quotes before you fill is normal and worthwhile.

Dose and package change the number

These medicines are taken weekly and the dose rises over the first months. Pens and packages cover different numbers of doses at different strengths, so a quote can be per pen, per package or per month, and higher doses can cost more per month. Make sure any quote you compare is actually for a month of treatment at your dose.

Discount routes apply unevenly

Savings cards, discount cards and assistance programs each work for some patients and not others, and each changes the price in a different way. That is most of why two people on the same medicine can pay very different amounts.

The compounded bracket

Below the branded prices sits a separate bracket. Compounded semaglutide is advertised from about $249 a month and compounded tirzepatide from about $379 a month. These are typical advertised starting prices for pharmacy prepared versions, not FDA approved products, and quality and dosing can vary. The compounded semaglutide guide explains what compounded means and the cautions the FDA publishes, and the compounded savings calculator compares the figures directly.

What lowers the real price

Manufacturer savings cards

Each manufacturer runs a savings card for patients with commercial insurance, under terms the manufacturer sets. These cards reduce the amount paid at the pharmacy for people whose insurance covers the medicine. They are not insurance, and they generally cannot be used with government insurance such as Medicare or Medicaid. The Wegovy coupon and Ozempic coupon guides explain how the cards work and how to spot fake coupon sites.

Patient assistance programs

Manufacturers also run patient assistance programs for people who meet the program's rules, which typically involve insurance status and income and are verified by the manufacturer. This page cannot tell you whether you qualify for anything. The manufacturer's own program pages are the only place to check, and our guide to getting a GLP-1 without insurance points to them in context.

Insurance and Medicare, in general

Coverage varies by plan and by diagnosis. GLP-1 medicines prescribed for type 2 diabetes are covered more often than the same class of medicine prescribed for weight management, and prior authorization from the prescriber is common either way. As of the sources used for this page, Medicare generally does not cover medicines prescribed only for weight loss under Part D, while diabetes use may be covered under a plan's own rules.

Costs beyond the pen

The medicine is the largest line, but it is not the only one. Consultations before and during treatment, follow up appointments and blood tests all sit around the prescription, and compounded routes can add program fees and supplies. None of these have a standard price, so this page does not put figures on them. The GLP-1 cost calculator frames the medicine cost itself over 3, 6 and 12 months.

Frequently asked questions

How much does a GLP-1 cost without insurance?

At approximate US list prices, the branded pens run from about $1,000 a month for Ozempic to about $1,350 a month for Wegovy, with Zepbound at about $1,060 and Mounjaro at about $1,080. Compounded versions are advertised from about $249 a month for semaglutide and about $379 for tirzepatide, but they are not FDA approved. Your actual quote depends on the pharmacy, the dose and any program you qualify for.

Why do different pharmacies quote different prices for the same medicine?

Pharmacies set their own cash prices, and discounts, coupons and supply contracts change the number at the register. The same pen at the same dose can therefore cost noticeably different amounts in different places. Asking for the cash price at two or three pharmacies, and asking which discounts apply, is worth the phone calls.

Does Medicare cover GLP-1 medicines?

It depends on the reason for the prescription and the plan. As of the sources used for this page, Medicare Part D generally does not cover medicines prescribed only for weight loss, while GLP-1 medicines prescribed for type 2 diabetes are covered by many plans under their own rules, usually with prior authorization. Check your own plan's formulary for your situation.

What is a manufacturer savings card?

It is a program run by the manufacturer that reduces what a patient with commercial insurance pays at the pharmacy, under terms the manufacturer sets. These cards generally cannot be used with government insurance such as Medicare or Medicaid, and they do not replace insurance. The official manufacturer websites carry the current terms and eligibility questions.

Are compounded GLP-1 medicines a safe way to cut the cost?

Compounded versions cost far less and many people use them, but they are not FDA approved, and the FDA has published cautions about dosing errors, salt forms of the ingredient and counterfeit products. If you consider this route, it should be with a prescription, a state licensed pharmacy and a prescriber who knows you are using it. Our compounded semaglutide guide explains the detail.

Sources. Approved uses and product details follow the FDA approved prescribing information published on DailyMed by the U.S. National Library of Medicine. Savings card and assistance descriptions follow the manufacturers' own program pages, which carry the current terms. Compounding cautions follow the FDA's public information on compounded GLP-1 products, and the Medicare description follows the general Part D coverage rules published by Medicare. Prices are the approximate figures used consistently across GLPKit.
Educational information only. Prices on this page are approximate US list prices or typical advertised starting prices at the time of writing. They vary by pharmacy, dose, presentation and program terms, and they change. This page is not medical or financial advice, and GLPKit does not sell medicines or process prescriptions. Confirm any price or program detail with the pharmacy, your plan or the manufacturer before relying on it.

Back to all GLPKit guides